Loading clinical trials...
Loading clinical trials...
A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)
Conditions
Interventions
AZD5851
AZD0754
Locations
25
United States
Research Site
Phoenix, Arizona, United States
Research Site
Duarte, California, United States
Research Site
Orange, California, United States
Research Site
San Francisco, California, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Jacksonville, Florida, United States
Start Date
September 17, 2025
Primary Completion Date
November 29, 2041
Completion Date
November 29, 2041
Last Updated
June 27, 2025
NCT07175441
NCT06594926
NCT06257264
NCT05969860
NCT06427941
NCT03620786
AstraZeneca Clinical Study Information Center
CONTACT
1-877-240-9479information.center@astrazeneca.comLead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions